Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 28 January

Paulina Peters
January 28, 2021

Morning Bell 27 January

Paulina Peters
January 27, 2021

Weekly Wrap 22 January

Jessica Amir
January 22, 2021

Morning Bell 22 January

Jessica Amir
January 22, 2021

Morning Bell 21 January

Jessica Amir
January 21, 2021

Morning Bell 20 January

Jessica Amir
January 20, 2021

Morning Bell 19 January

Jessica Amir
January 19, 2021

Morning Bell 18 January

Jessica Amir
January 18, 2021

Weekly Wrap 15 January

Jessica Amir
January 15, 2021

Morning Bell 15 January

Jessica Amir
January 15, 2021

Morning Bell 14 January

Jessica Amir
January 14, 2021